arrow
返回
C

Chu Lin

xicheng district

15H指数
81论文数
783被引数
收录论文 58
发表时间
Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM)
err2025-02-08
err0
errOAAI
errFang, Yayu; Liu, Wei; Cai, Xiaoling; Zhu, Yu; Zhang, Mingxia; Gong, Siqian; Wang, Xiangqing; Lin, Chu; Zhang, Rui; Yin, Sai; Li, Juan; Huo, Yongran; Hu, Xiaodan; Xie, Xiaoqi; Ji, Linong
err分享
err收藏
Development and external validation of an algorithm for self-identification of risk for microvascular complications in patients with type 1 diabetes
err2024-11-25
err0
PREAI
errLiu, Wei; Hu, Xiaodan; Fang, Yayu; Hong, Shenda; Zhu, Yu; Zhang, Mingxia; Gong, Siqian; Wang, Xiangqing; Lin, Chu; Zhang, Rui; Yin, Sai; Li, Juan; Huo, Yongran; Cai, Xiaoling; Ji, Linong
err分享
err收藏
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
err2024-11-21
err1
PREAI
errZhang, Mengqing; Lin, Chu; Cai, Xiaoling; Jiao, Ruoyang; Bai, Shuzhen; Li, Zonglin; Lv, Fang; Yang, Wenjia; Liu, Geling; Yang, Xiaolin; Ji, Linong
err分享
err收藏
Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis
err2024-10-21
err2
PREAI
errJiao, Ruoyang; Lin, Chu; Cai, Xiaoling; Wang, Jingxuan; Wang, Yuan; Lv, Fang; Yang, Wenjia; Ji, Linong
err分享
err收藏
err分享
err收藏
The association between the eGFR slope and cardiorenal prognosis in patients with renoprotective treatments: A systematic review and meta-analysis
err2024-09-19
err0
PREAI
errBai, Shuzhen; Lin, Chu; Cai, Xiaoling; Wu, Han; Jiao, Ruoyang; Hu, Suiyuan; Lv, Fang; Yang, Wenjia; Ji, Linong
err分享
err收藏
The Association between GLP-1 Receptor-Based Agonists and the Incidence of Asthma in Patients with Type 2 Diabetes and/or Obesity: A Meta-Analysis* *
err2024-07-01
err1
PREAI
errZhang, Mengqing; Lin, Chu; Cai, Xiaoling; Jiao, Ruoyang; Bai, Shuzhen; Li, Zonglin; Hu, Suiyuan; Lyu, Fang; Yang, Wenjia; Ji, Linong
err分享
err收藏
The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis
err2024-05-01
err2
errOAAI
errLin, Chu; Hu, Suiyuan; Cai, Xiaoling; Lv, Fang; Yang, Wenjia; Liu, Geling; Yang, Xiaolin; Ji, Linong
err分享
err收藏